Newton Biocapital invests in PRISM BioLab to support development of a unique peptide mimetic technology platform to discover new drugs for intractable diseases
Brussels, Belgium / Tokyo, Japan – 9 September 2021 – Newton Biocapital (“Newton”), a life sciences investment fund active in […] September 9, 2021 · Turnstone Communications
Article
Cancer diagnosis and therapy in one: Precirix tackles tumors with camelid antibodies
A new drug that can identify tumors, trace metastases, and treat cancer – all in one? Belgian start-up Precirix is […] August 18, 2021 · V-Bio Ventures
Article
Betting on the best egg: Aurora test doubles pregnancy chances in assisted conception
Assisted conception techniques have matured in the last few decades, with Belgian scientists playing a big part in the progress. […] August 18, 2021 · BioVoxSpectricity Raises €14 Million Series B Funding as it Accelerates Plans to Deliver Industry Leading Hyperspectral Sensing to Mobile and Consumer Devices
Funding Expands Growth for Tiny Chip-size Sensors for Unimaginable New Applications. Mechelen, Belgium, August 3rd, 2021 – Spectricity, a leading provider of hyperspectral […] August 3, 2021 · Turnstone CommunicationsArdena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands
Ghent, Belgium, 14 July 2021 – Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO), in partnership with GHO Capital, […] July 14, 2021 · Turnstone CommunicationsAzalea Vision closes € 8 million Series A to develop a smart contact lens for light sensitivity and ocular disorders
Azalea Vision develops autonomous smart solutions embedded inside a contact lens to improve the quality of life of people with […] July 8, 2021 · Turnstone CommunicationsNewton Biocapital invests in EditForce to support development of a unique DNA/RNA editing platform based on PPR protein technology
Brussels, Belgium / Tokyo, Japan – 1 July 2021 – Newton Biocapital (“Newton”), a life sciences investment fund active in […] July 1, 2021 · Turnstone Communications
Article
Moderna: from secretive platform company to vaccine superstar
Moderna Therapeutics has never really been a typical biotech. Sure, nowadays it is world famous thanks to its COVID-19 vaccine, […] June 23, 2021 · V-Bio Ventures
Article
Friend or foe: building a healthy relationship with your board
CEOs of start-ups face many challenges. Among many tasks, they have to set up the organization, write the business plan, […] June 23, 2021 · V-Bio VenturesNewton Biocapital invests in NeuVasQ: EUR 20 million Series A to develop unique blood-brain barrier therapy
– Newton together with public and private investment partners invests in NeuVasQ for the development of blood-brain barrier pharmaceuticals based […] June 22, 2021 · Turnstone Communications
Article
Malaria vaccine candidate shows promise for African children
Despite decades of research, scientists have so far been unable to develop a fully effective vaccine for malaria. Now, a […] June 16, 2021 · BioVox
Article
SciMingo: bringing science to the center stage
The world needs more quality science communication. The value to society is evident, as clear communication is key to science-based […] June 16, 2021 · BioVoxMontis Biosciences Awarded VLAIO Grant to Expand its Pipeline of Novel Immune-Oncology Therapeutics
Leuven, Belgium, 14 June 2021 – Montis Biosciences, a Belgium-based biotech company focused on the development of novel immuno-oncology therapeutics targeting the […] June 14, 2021 · Turnstone Communications
Article
Trusting gut bacteria: MRM Health develops microbiome treatments for IBD and more
In the last decade, there has been a growing interest in the potential of microbiome-based therapeutics: using gut bacteria as […] May 19, 2021 · BioVoxGround-breaking Flemish health projects go virtual: Smart Hub Flemish Brabant launches Health Experience
Smart Hub Flemish Brabant has launched the innovative online platform ‘Health Experience’. The virtual tour gives exclusive insights into the […] May 18, 2021 · Turnstone CommunicationsDroia Ventures raises a new fund of EUR 220 million to target genetic diseases and expands leadership team with George Golumbeski
Brussels, Belgium, 11 May 2021 – Droia Ventures today announced the final closing of its third fund, having raised EUR […] May 11, 2021 · Turnstone CommunicationsPulsify Medical closes second round Series A funding of EUR 6.35 million for wearable ultrasound heart monitor patch
Pulsify Medical is developing wearable ultrasound patches to monitor vital human organs such as the heart. The company has announced […] May 4, 2021 · Turnstone Communications
Article
Belgian pharma industry among the EU’s strongest despite pandemic setbacks
How did the Belgian chemical and pharmaceutical sector fare during the first year of the pandemic? A recent report from […] April 28, 2021 · BioVox
Article
To fund or not to fund: the psychology of investment decisions
Much has been written about the psychology of decision making and how venture capitalists choose which companies they want to […] April 28, 2021 · V-Bio Ventures
Article
Beer, bread and bioethanol: SUPERYEAST project to improve industry sustainability
Prof. Kevin Verstrepen, of the VIB-KU Leuven Center for Microbiology, has received a prestigious ERC Proof of Concept grant for […] April 28, 2021 · BioVox
Article
Antwerp start-up to convert CO2 into industry building blocks
The University of Antwerp spin-off D-CRBN is helping carbon-emitting industries transform greenhouse gases into useful products. Using plasma technology, the […] April 28, 2021 · BioVoxProteomics PharmaFluidics Launches Next Generation µPAC™ Technology for Routine Proteomics
Microfluidic chips for use in high-resolution nanoLC/MS workflows Ghent, Belgium, 27 April 2021 – PharmaFluidics NV, innovative life sciences instruments […] April 27, 2021 · Turnstone CommunicationsV-Bio Ventures invests in new start-up Protealis to uplift sustainable plant protein production
Ghent, Belgium, 8 April 2021 – Today V-Bio Ventures announces its investment in Ghent-based company Protealis, a new spin-off from […] April 8, 2021 · V-Bio Ventures
Article
AgomAb’s journey of growth in regenerative medicine
Ghent-based AgomAb Therapeutics recently raised a Series B of $74 million, the largest round ever for a Belgian biotech in […] March 31, 2021 · V-Bio Ventures
Article
Soy in 1000 gardens: citizen science project to map soil microbes in Flanders
Good science takes many hands. In the case of a new citizen science project by VIB, UGent, ILVO, KU Leuven, […] March 31, 2021 · BioVox
Sponsored
Augustine Therapeutics developing new medicines for neuromuscular diseases
Augustine Therapeutics had a lot of announcements this month: the VIB spin-off just appointed Dr. Sylvain Celanire as CEO, strengthened […] March 31, 2021 · Turnstone Communications
Article
Wallonia to invest in plant-based proteins as meat substitutes
The Walloon region is taking major steps towards becoming an important player in the business of plant-based proteins. In the […] March 31, 2021 · BioVoxMontis Biosciences appoints René Hoet as Chief Scientific Officer
Leuven, Belgium, 31 March 2021 – MONTIS BIOSCIENCES, a discovery stage biotech company focused on the development of novel immuno-oncology therapeutics […] March 31, 2021 · Turnstone CommunicationsAugustine Therapeutics awarded EUR 1.2 million VLAIO research grant to develop new medicines for neuromuscular diseases
Leuven, Belgium, 23 March 2021 – Augustine Therapeutics, a biotech spin-out company from VIB that focuses on the development of […] March 23, 2021 · Turnstone CommunicationsAugustine Therapeutics strengthens Board of Directors and sets up Scientific Advisory Board
Leuven, Belgium, 19th March 2021 – Augustine Therapeutics, a biotech company focused on the development of innovative medicines for rare […] March 19, 2021 · Turnstone CommunicationsAugustine Therapeutics appoints Sylvain Celanire as CEO to accelerate development of innovative medicines for rare neuromuscular diseases
Leuven, Belgium, 18th March 2021 – Augustine Therapeutics, a biotech company focused on the development of innovative medicines for rare […] March 18, 2021 · Turnstone Communications
Sponsored
Lessons learned from COVID-19: how do we prepare for the next pandemic?
Although the crisis has not yet passed, COVID-19 has already taught us many valuable lessons. This past year has tested […] March 10, 2021 · Turnstone Communications
Article
Record-breaking pollen levels linked to increased risk of COVID-19
Increased pollen concentrations are correlated with higher rates of COVID-19. Hot on the heels of record-breaking European pollen counts, this […] March 10, 2021 · BioVox
Article
Saving man’s best friend: Volition blood test allows cheap and easy cancer screenings for dogs
A Belgian invention is revolutionizing cancer diagnostics for dogs by making it possible to screen for two common canine cancers […] March 10, 2021 · BioVoxRejuvenate Biomed Secures EUR 3.2 Million Series A Round to Advance Development of Healthy Aging Products
Heusden-Zolder, Belgium, 2 March 2021 – Rejuvenate Biomed NV (“Rejuvenate”), a biomedical company developing prescription drugs for age-related diseases, announces […] March 2, 2021 · Turnstone Communications
Article
V-Bio Ventures: a fresh fund with a difference
V-Bio Ventures recently announced their second fund, with the first closing already totaling 78 million euros. As a VC fund […] February 24, 2021 · V-Bio VenturesNewton Biocapital invests in Flemish start-up DeuterOncology
Brussels, Belgium, 24 February 2021 – Newton Biocapital I (“Newton Biocapital”), a life sciences investment fund active in Europe and […] February 24, 2021 · Turnstone CommunicationsPreventive saliva test for detecting the COVID-19 virus is now available to companies and organizations
Ghent, Belgium, 23 February 2021 – The Ghent company Biogazelle and the medical laboratory Labo Nuytinck (Ghent, Evergem), together with […] February 23, 2021 · Turnstone CommunicationsPharmaFluidics Announces Ultra-Sensitive Second Generation µPAC™ Technology for Unbiased Single Cell Proteomics
Micro-chip based µPAC™ LC columns – key component in Vienna IMP study measuring the proteome at picogram level Ghent, Belgium, […] February 17, 2021 · Turnstone CommunicationsOnco-immunology Company Pan Cancer T Launched as Spin-off from Erasmus Medical Center
– Dutch biotech company developing first-in-class T-cell Receptor (TCR) T-cell therapies – Seed investment by Swanbridge Capital and Van Herk […] February 8, 2021 · Turnstone CommunicationsV-Bio Ventures launches its second fund at EUR 78 million
– First Closing of V-Bio Fund 2 is announced at EUR 78 million – V-Bio Fund 2 will ensure seamless […] February 4, 2021 · V-Bio VenturesDoseVue obtains CE Mark for its first in-vivo dosimetry product for radiation therapy
Diepenbeek, Belgium – January 28, 2021 – DoseVue NV, a privately held medical device company developing in-vivo dosimetry solutions for […] January 28, 2021 · Turnstone Communications
Article
One year of COVID-19: a look back at 2020 and where we are now
One year on from the emergence of SARS-COV-2 in Wuhan, China, this novel coronavirus continues to devastate the world. Since […] January 27, 2021 · BioVox
Article
Prestigious prize for Belgian breakthrough in brain research
Prof. Dr. Pierre Vanderhaeghen from VIB-KU Leuven has been awarded the Generet Prize for Rare Diseases for his research on […] January 27, 2021 · BioVox
Article
New VIB incubator gives agbiotech start-ups a chance to flourish
In mid-2021, research institute VIB will open its brand-new agbiotech incubator. The new complex will provide entrepreneurs with access to […] January 27, 2021 · BioVox
Article
How to build the right team for start-up success
One of the key ingredients to start-up success is a stellar management team. Attracting (and retaining) the right kind of […] January 27, 2021 · V-Bio Ventures
Article
Decades-old discoveries cause paradigm shifts in modern medicine
Complete paradigm shifts in medicine are rare, but there have nevertheless been several major examples in the past hundred years. […] December 16, 2020 · V-Bio Ventures
Sponsored
The rapid evolution of Chinese biotech
The world is smaller today than it has ever been. With the COVID-19 pandemic, we have seen the advantages of […] December 2, 2020 · Turnstone Communications
Sponsored
Belgian biotechs partnering with China: deals of 2020
In 2019, a delegation of Belgian biotechs participated in an economic mission to China led by H.R.H. Princess Astrid. Co-organized […] December 2, 2020 · Turnstone Communications
Sponsored
Long-term loyalty: A Belgian fund’s perspective on Chinese investors
Over the past few years, an increasing number of European biotechs have been signing deals with Chinese investors. The Chinese […] December 2, 2020 · Turnstone CommunicationseTheRNA and China Grand Pharma enter a strategic collaboration in the Greater China Region focussed on eTheRNA’s proprietary mRNA development products and manufacturing capabilities
Niel, Belgium, 1 December 2020 – eTheRNA immunotherapies NV (“eTheRNA”) announced it has entered into a strategic cooperation and product […] December 2, 2020 · Turnstone CommunicationsNewton Biocapital I invests in Perseus Proteomics Inc. in Japan to develop therapeutic antibodies for the treatment of blood cancers
Brussels, Belgium / Tokyo, Japan – 1 December 2020 – Newton Biocapital I (“Newton”), a life sciences investment fund active in Europe […] December 1, 2020 · Turnstone Communications
Article
A life-changing discovery: CRISPR scientists awarded the 2020 Nobel Prize in Chemistry
After several years of nominations, Emmanuelle Charpentier and Jennifer Doudna have finally been awarded the 2020 Nobel Prize in Chemistry […] November 4, 2020 · BioVox
Article
An insightful solution to eye injections
Developing new therapies is sometimes not enough: for retinal indications, accurate delivery is key to making a drug work. Lowering […] November 4, 2020 · V-Bio Ventures
Article
Vascular dysfunction meets immune suppression
November 4, 2020 · BioVox
Article
New initiative to promote transition to Organ-on-Chip technology
In an effort to raise awareness for alternatives to animal models, BioVox is helping to promote an Organ-on-Chip initiative by […] October 29, 2020 · BioVoxV-Bio Ventures invests in new start-up Animab in a EUR 3.4 million Seed Financing to improve health and performance of livestock animals
Gent, Belgium, 27 October 2020 – Today V-Bio Ventures announces its investment in Animab, a new venture spin-off from VIB, in a EUR […] October 27, 2020 · V-Bio Ventures
Article
Belgium: the number one biotech country in Europe!
For the third year in a row, Belgium has been ranked the number one country in Europe for biotech! Belgium […] September 30, 2020 · BioVox
Article
Get to know Lewis Cantley: winner of the 2020 Dr. Paul Janssen Award
Every year, the Dr. Paul Janssen Award for Biomedical Research is granted to a scientist who embodies the eponymous man’s […] September 30, 2020 · Janssen Pharmaceutica
Article
UAntwerp researchers find cause for mysterious nodding syndrome
For decades, researchers have been trying to uncover the cause of nodding syndrome, a mysterious and deadly form of epilepsy […] September 30, 2020 · BioVox
Article
Can Darwin’s theory explain why we get sick?
While physicians care for their individual patients and are interested in the factors contributing to the individual’s condition, evolutionary biologists […] September 30, 2020 · V-Bio VenturesMontis Biosciences appoints Karen Zinkewich-Péotti as Chief Executive Officer
Leuven, Belgium, 29 September 2020 – Montis Biosciences, a discovery stage biotech company focused on novel immuno-oncology therapeutics targeting the […] September 29, 2020 · Turnstone Communications
Article
Countering COVID-19 with llama antibodies
Last month, VIB spin-off ExeVir Bio raised €23 million to advance a llama-derived antibody against COVID-19. The company is based […] August 31, 2020 · BioVox
Article
A novel approach to neurology could bring relief to people in pain
In August 2020, V-Bio Ventures announced their investment in Biodol Therapeutics, a French start-up looking to make a difference to […] August 31, 2020 · V-Bio Ventures
Sponsored
Belgian stem cell company GST bought by German pharmaceutical giant
The German pharmaceutical giant Boehringer Ingelheim has acquired GST, a stem cell specialist based in Belgium. A part of the […] August 31, 2020 · Turnstone Communications
Article
Drug combos: how much is 1 + 1?
Many of our current antiviral, antibacterial and anti-tumour medications are comprised of combinations of two or three active substances, selected […] August 31, 2020 · V-Bio VenturesBiodol Therapeutics receives EUR 4.5 million to progress its novel pain medication in a Series A led by V-Bio Ventures
V-Bio Ventures, a leading Belgian life sciences VC, invests in Biodol Therapeutics, a French biotech specialized in next-generation chronic pain […] August 31, 2020 · V-Bio VenturesNewton Biocapital I invests in J-Pharma Co., Ltd. in Japan focusing on drug development targeting L-type Amino Acid Transporter 1 (LAT1) for cancer and autoimmune diseases
Brussels, Belgium / Tokyo, Japan – 27 August 2020 – Newton Biocapital I (“Newton”), an investment company in life sciences, […] August 27, 2020 · Turnstone CommunicationsLewis Cantley awarded Dr. Paul Janssen Award for Biomedical Research 2020
Johnson & Johnson Celebrates Role of Scientists In Society with 2020 Dr. Paul Janssen Award for Biomedical Research, Part of […] August 21, 2020 · Janssen PharmaceuticaV-Bio invests into ExeVir Bio to accelerate development of new treatment conferring broad protection against Covid-19
Ghent, Belgium, 28 July 2020 – Today V-Bio Ventures announces its investment in a EUR 23 million Series A financing into ExeVir Bio. […] July 28, 2020 · V-Bio VenturesAnacura, a Belgian biotech company, sells stem cell business to Boehringer Ingelheim
Ghent, Belgium, 27 July 2020 – GST, the stem cell specialist for horses and pets within the Anacura Group, has […] July 27, 2020 · Turnstone Communications
Sponsored
Building bigger for Belgium’s maturing biotech scene
Biotech is booming in Belgium. To support the evolving needs of this world-class ecosystem, the Mariën family initiated and are […] July 7, 2020 · Turnstone Communications
Article
VIB: the driving force behind a booming biotech ecosystem
Since VIB was established, the world class research institute has been led by a duo of managing directors. As Johan […] July 7, 2020 · BioVox
Article
The opioid epidemic: solutions to a painful problem
Opioid misuse is a public health crisis that has resulted in debilitation, deaths, and significant social and economic impact. The […] July 7, 2020 · V-Bio Ventures
Article
Colorectal cancer discovery raises hope for microbiome treatment
A new mechanism causing colorectal cancer has been discovered by researchers from VIB and Ghent University. A specific protein was […] July 7, 2020 · BioVoxMax Planck researchers feed Proteome AI with PharmaFluidics technology
Micro-chip based µPAC™ LC columns – key component in NATURE study doubling the universe of known proteins across all kingdoms […] June 18, 2020 · Turnstone Communications
Article
To prevent another pandemic, we need to improve our relationship with animals
The new coronavirus did not come as a bolt from the blue. For many years, the World Health Organization (WHO) […] June 8, 2020 · BioVox
Article
How changing diets gave rise to the world’s deadliest diseases
This article was authored by Ward Capoen from V-Bio Ventures. In a recent article, we discussed how the most prescribed […] June 8, 2020 · V-Bio Ventures
Article
Fundamental research leads to treatment breakthrough in rare genetic diseases
A basic research breakthrough is improving patient lives, as researchers realized their rare genetic condition could be treated by repurposing […] June 8, 2020 · BioVox
Article
Talking T cells with David Masopust
Immunology is a complex but vitally important branch of the life sciences. Earlier this year, we attended a Keystone Symposia […] June 8, 2020 · BioVoxPharmaFluidics awarded VLAIO research grant
Funding will support product range extension of micro-chip based µPAC™ nano, capillary and microflow LC columns, and accelerated development of […] June 2, 2020 · Turnstone Communications
Article
Onno van de Stolpe talks Belgian biotech
At this year’s Innovation for Health, we sat down for a chat with Onno van de Stolpe. Winner of the […] May 5, 2020 · BioVox
Article
Cell therapies: opportunities and challenges
This article was authored by Christina Takke from V-Bio Ventures. Recent activities in the cell therapy field have prompted many […] May 5, 2020 · V-Bio Ventures
Article
TheSocialMedwork: equal access to medicines for everyone, everywhere
We recently sat down with Sjaak Vink, the visionary entrepreneur behind TheSocialMedwork. This enterprise gives patients all over the world […] May 5, 2020 · BioVox
Article
Belgian clinical trials for COVID-19
With COVID-19 cases soaring into the millions, and a vaccine still a ways off, patients are desperate for a treatment. […] May 5, 2020 · BioVoxBioVox: the global network for Belgian life sciences turns five and launches a new website!
May 4, 2020 · Turnstone Communications
Article
Potential impact of the corona crisis on the life sciences industry
This article was authored by Christina Takke from V-Bio Ventures Over the past few months, every news headline has focused […] March 26, 2020 · V-Bio Ventures
Article
University Hospital Ghent and VIB are testing medication to treat COVID-19-associated respiratory illness
University Hospital Ghent and VIB are assessing a drug called Leukine® to treat patients with respiratory illness associated with COVID-19. Major medical centers in [...] March 25, 2020 · BioVox
Article
Why Are Start-Ups Such Hotbeds For Innovation?
A large proportion of new treatments and life sciences breakthroughs can often be traced back to humble beginnings in a […] January 20, 2020 · V-Bio VenturesBiogazelle initiates large-scale testing of COVID-19 in Belgium
Ghent, Belgium, April 2, 2020 – Biogazelle NV, a CRO specialized in RNA analytics, has announced the initiation of large-scale testing of patient samples for SARS-CoV-2. [...] April 2, 2020 · Turnstone Communications
News
ElmediX wants to stop coronavirus by heating patients in a controlled manner
Mechelen, Belgium, 24 March 2020 – The coronavirus has brought the whole world to a standstill. The Belgian company ElmediX wants to contain the virus with intensive [...] March 24, 2020 · Turnstone Communications
Article
Janssen Pharmaceutica and Filliers Distillery make disinfectant hand gel
Pharmaceutical company Janssen Pharmaceutica and gin distillery Filliers Distillery are making disinfectant hand gel from Sunday. They will distribute it among the Belgian hospitals. March 24, 2020 · Janssen Pharmaceutica
Article
Professors of Product Development from UAntwerp are looking at emergency production of mouth masks
At the University of Antwerp, twelve product developers are working day and night to develop oral masks. “Together with industrial partners, we try to set up an [...] March 24, 2020 · BioVox
Article
The long-distance race for a corona vaccine
Developing a vaccine takes a long time and occurs in different phases. A virus spreads quickly and unpredictably. Therefore, the outcome is a gamble for anyone in the race for the corona vaccine. March 24, 2020 · BioVox
Article
Gates Foundation commissions large coronavirus study from KU Leuven
The Bill & Melinda Gates Foundation is to provide samples of 15,000 therapeutic molecules to the Gasthuisberg hospital at the University of Leuven, to aid research into therapies to combat the coronavirus COVID-19, De Standaard reports. March 24, 2020 · BioVox
Article
VIB achieves important milestone in the development of a COVID-19 drug
Earlier this year, the lab of Xavier Saelens (VIB-UGent) announced the discovery of a unique antibody that is capable of binding the virus that causes COVID-19 (SARS-CoV-2). [...] March 24, 2020 · BioVox
Article
Augustine Therapeutics: bridging the valley of death with VIB Discovery Sciences
Augustine Therapeutics is one of VIB’s latest spinoffs, developing a first-in-class drug for Charcot-Marie-Tooth disease. The company recently announced a seed-funding [...] February 26, 2020 · V-Bio Ventures
Article
Why everyone needs to be a part of the CRISPR conversation
With the soaring cost of drugs for rare indications, many biotech and pharmaceutical companies are focusing R&D efforts on orphan diseases. Will the pendulum swing back towards more common maladies? February 26, 2020 · BioVox
Article